PE Ratio
20.19
-2.53-11.14%
8 min ago
Summary
- As of March 10, 2025, RIGL price to earnings ratio is 20.19, with a fall of -2.53 (-11.14%) during the most recent trading day.
- RIGL PE ratio is now -86.35% below its all-time high of 147.95.
Performance
RIGL PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
RIGL PE Ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -11.1% | -11.1% | +394.7% | +13.8% |
| 1 m1 month | -11.6% | -11.6% | - | - |
| 3 m3 months | -81.3% | -7.7% | 0.0% | 0.0% |
| 6 m6 months | - | +44.1% | - | - |
| ytdytd | +11.9% | +11.8% | - | - |
| 1 y1 year | - | +20.9% | 0.0% | 0.0% |
| 5 y5 years | - | -5.1% | 0.0% | 0.0% |
RIGL PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -20.5% | 20.19 | at low | |
| 3 m | 3-month | 132.21 | -84.7% | 16.97 | +19.0% |
| 6 m | 6-month | 147.95 | -86.3% | 16.97 | +19.0% |
| 1 y | 1-year | 147.95 | -86.3% | 16.97 | +19.0% |
| 3 y | 3-year | 147.95 | -86.3% | 16.97 | +19.0% |
| 5 y | 5-year | 147.95 | -86.3% | 16.97 | +19.0% |
| alltime | all time | 147.95 | -86.3% | 9.21 | +119.2% |
Rigel Pharmaceuticals PE Ratio History
| Date | Value |
|---|---|
| 2025 | 20.19(+11.9%) |
| Date | Value |
|---|---|
| 2024 | 18.05(+70.1%) |
| 2010 | 10.61 |
FAQ
- What is Rigel Pharmaceuticals price to earnings ratio?
- What is the all time high PE ratio for Rigel Pharmaceuticals?
- What is RIGL price to earnings ratio year-to-date change?
What is Rigel Pharmaceuticals price to earnings ratio?
The current PE ratio of RIGL is 20.19
What is the all time high PE ratio for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high price to earnings ratio is 147.95
What is RIGL price to earnings ratio year-to-date change?
Rigel Pharmaceuticals price to earnings ratio has changed by +2.14 (+11.86%) since the beginning of the year